Radiation Therapy for Benign Conditions
This educational series explores the evolving role of radiation therapy in managing non-malignant conditions, addressing current challenges, emerging evidence, and specialized applications in clinical practice.
TOPICS COVERED
- Pearls and Pitfalls in Non-Malignant Radiation Therapy: Challenging Case Presentations
- Updates on Low Dose Radiotherapy for Osteoarthritis
- Radiation Therapy for Non-Malignant CNS Disorders
Please see the Program tab for the session descriptions and presenters.
This activity is available from September 15, 2025 through 11:59 pm Eastern time on September 14, 2027.
Target Audience
This activity is designed to meet the interests of radiation oncologists, medical oncologists, nurses, diagnostic radiologists, physicists, dosimetrists, radiation biologists, radiation therapists, residents and allied healthcare professionals interested in radiation therapy for non-malignant conditions.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Understand technical considerations and outcome optimization in benign condition management.
- Gain insight into the practice-changing developments for benign condition management and be aware of future directions.
- Learn about the specialized application of radiation therapy for neurological and psychiatric conditions as well as neurodegenerative diseases.
Pearls and Pitfalls in Non-Malignant Radiation Therapy: Challenging Case Presentations
October 15, 2025 - 12:00 p.m - 1:00 p.m.
- M. Heinrich Seegenschmiedt, MD, PhD
- Richard Shaffer, MBBS, MD
- Moderator: Bobby Koneru, MD, FASTRO
Through a series of complex clinical scenarios, this webinar will examine decision-making strategies, technical considerations, and outcome optimization in benign condition management. Expert faculty will present challenging cases highlighting best practices, common complications, and lessons learned from difficult clinical situations.
Updates on Low Dose Radiotherapy for Osteoarthritis
Date: TBD
- Austin Dove, MD
- Moderator: Bobby Koneru, MD, FASTRO
This webinar will focus on reviewing the most recent literature that has been published on the use of low dose radiation for osteoarthritis. The discussion will highlight the most recently presented and published studies including multiple prospective clinical trials. As evidence continues to strengthen for the use of low dose radiation, this discussion will highlight the most important studies and techniques used for modern low dose radiation.
Radiation Therapy for Non-Malignant CNS Disorders
Date: TBD
- Evan Thomas, MD, PhD
- Moderator: Bobby Koneru, MD, FASTRO
Focused on the specialized application of radiation therapy for neurological and psychiatric conditions, this webinar will cover treatment approaches for neurodegenerative diseases (Alzheimer's, Parkinson's), refractory depression, and other CNS disorders. Discussion will include current literature, clinical trials, patient selection criteria, technique optimization, and multidisciplinary care coordination.
- Nagendra (Bobby) Koneru, MD, FASTRO, is employed by FHN Memorial Hospital.
- M. Heinrich Seegenschmiedt, MD, PhD, is employed by MVZ Ruhrradiologie Rur191.
- Richard Shaffer, MBBS, MD, is employed by RT-ABC Ltd., GenesisCare UK and TheraLife Clinics.
- Austin Dove, MD, is employed by Tennessee Oncology.
- Evan Thomas, MD, PhD, is employed by Renaissance Institute of Precision Oncology and Radiosurgery.
The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity. All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 3.00 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 3.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.00 Certificate of AttendanceThis activity was designated for 3.00 AMA PRA Category 1 Credit™.
Price
Course fees:
ASTRO members must log in to the ASTRO website to view and receive the member rate.
Member: $199
Member-in-training: $99
Member Student/Grad Student/PGY: $99
Member Postdoctoral Fellow: $99
Nonmember: $299
If you are an ASTRO member from a low or lower-middle income country, as identified by the World Bank, you can receive a 50% discount off your corresponding registration for this activity. Please email [email protected] to inquire about the discount.
Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until September 14, 2027, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.